Logo image of RANI

RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Overview

NASDAQ:RANI - US7530181004 - Common Stock

0.46 USD
-0.03 (-5.23%)
Last: 9/4/2025, 8:00:01 PM
0.4728 USD
+0.01 (+2.78%)
Pre-Market: 9/5/2025, 4:50:30 AM

RANI Key Statistics, Chart & Performance

Key Statistics
52 Week High3.75
52 Week Low0.39
Market Cap33.06M
Shares71.87M
Float38.53M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.91
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-30 2021-07-30
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


RANI short term performance overview.The bars show the price performance of RANI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

RANI long term performance overview.The bars show the price performance of RANI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of RANI is 0.46 USD. In the past month the price decreased by -16.32%. In the past year, price decreased by -82.44%.

RANI THERAPEUTICS HOLDINGS-A / RANI Daily stock chart

RANI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46 703.13B
JNJ JOHNSON & JOHNSON 17.88 430.51B
AZN ASTRAZENECA PLC-SPONS ADR 18.42 253.56B
NVO NOVO-NORDISK A/S-SPONS ADR 14.39 249.45B
NVS NOVARTIS AG-SPONSORED ADR 14.51 248.60B
MRK MERCK & CO. INC. 10.92 209.94B
PFE PFIZER INC 7.24 139.52B
SNY SANOFI-ADR 10.26 110.56B
BMY BRISTOL-MYERS SQUIBB CO 6.94 95.03B
GSK GSK PLC-SPON ADR 8.78 79.80B
ZTS ZOETIS INC 24.63 67.90B
TAK TAKEDA PHARMACEUTIC-SP ADR 52.72 48.29B

About RANI

Company Profile

RANI logo image Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company is headquartered in San Jose, California and currently employs 105 full-time employees. The company went IPO on 2021-07-30. The firm has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The company has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. The company is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).

Company Info

RANI THERAPEUTICS HOLDINGS-A

2051 Ringwood Avenue

San Jose CALIFORNIA US

CEO: Talat Imran

Employees: 106

RANI Company Website

RANI Investor Relations

Phone: 14084573700

RANI THERAPEUTICS HOLDINGS-A / RANI FAQ

What is the stock price of RANI THERAPEUTICS HOLDINGS-A today?

The current stock price of RANI is 0.46 USD. The price decreased by -5.23% in the last trading session.


What is the ticker symbol for RANI THERAPEUTICS HOLDINGS-A stock?

The exchange symbol of RANI THERAPEUTICS HOLDINGS-A is RANI and it is listed on the Nasdaq exchange.


On which exchange is RANI stock listed?

RANI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for RANI THERAPEUTICS HOLDINGS-A stock?

9 analysts have analysed RANI and the average price target is 8.93 USD. This implies a price increase of 1840.22% is expected in the next year compared to the current price of 0.46. Check the RANI THERAPEUTICS HOLDINGS-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is RANI THERAPEUTICS HOLDINGS-A worth?

RANI THERAPEUTICS HOLDINGS-A (RANI) has a market capitalization of 33.06M USD. This makes RANI a Nano Cap stock.


How many employees does RANI THERAPEUTICS HOLDINGS-A have?

RANI THERAPEUTICS HOLDINGS-A (RANI) currently has 106 employees.


What are the support and resistance levels for RANI THERAPEUTICS HOLDINGS-A (RANI) stock?

RANI THERAPEUTICS HOLDINGS-A (RANI) has a resistance level at 0.55. Check the full technical report for a detailed analysis of RANI support and resistance levels.


Should I buy RANI THERAPEUTICS HOLDINGS-A (RANI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RANI THERAPEUTICS HOLDINGS-A (RANI) stock pay dividends?

RANI does not pay a dividend.


What is the Price/Earnings (PE) ratio of RANI THERAPEUTICS HOLDINGS-A (RANI)?

RANI THERAPEUTICS HOLDINGS-A (RANI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.91).


What is the Short Interest ratio of RANI THERAPEUTICS HOLDINGS-A (RANI) stock?

The outstanding short interest for RANI THERAPEUTICS HOLDINGS-A (RANI) is 0.68% of its float. Check the ownership tab for more information on the RANI short interest.


RANI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

RANI Financial Highlights

Over the last trailing twelve months RANI reported a non-GAAP Earnings per Share(EPS) of -0.91. The EPS increased by 22.88% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -175.68%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%30.77%
Sales Q2Q%N/A
EPS 1Y (TTM)22.88%
Revenue 1Y (TTM)N/A

RANI Forecast & Estimates

9 analysts have analysed RANI and the average price target is 8.93 USD. This implies a price increase of 1840.22% is expected in the next year compared to the current price of 0.46.


Analysts
Analysts82.22
Price Target8.93 (1841.3%)
EPS Next Y50.44%
Revenue Next YearN/A

RANI Ownership

Ownership
Inst Owners11.97%
Ins Owners1.76%
Short Float %0.68%
Short Ratio0.12